| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |